Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be a minor site maintenance update that does not alter the page content.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study details, eligibility criteria, or results content.SummaryDifference0.1%

- Check17 days agoChange DetectedFooter area now includes labels/links for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with a 'Helpful Links Provided by' note.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedDeleted sponsor attribution and navigation links (H. Lee Moffitt Cancer Center and Research Institute; Moffitt Cancer Center Clinical Trials website; Helpful Links) from the study page. This reduces visible context about the study's sponsor and related resources, affecting how users identify provenance and access additional information.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.4.2 has been added. The notice about government funding lapse and the older Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check46 days agoChange DetectedA new site-wide notice informs users about a lapse in government funding and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for updates. Revision: v3.4.1 replaces the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.